Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep532 | Diabetes complications | ECE2017

New features of pathogenetic treatment of diabetic neuropathy (DN) at on early stage

Yerdesova Kulshara , Myrzabaeva Aknur

Goal of research: To evaluate the clinical efficacy of phosphocreatine in the combined metabolic therapy of diabetic neuropathy at an early stage.Materials and methods: A pilot study was carried out with participation of 36 patients suffering from DM 2. Using the method of randomization the patients were divided into two groups. Apart from the standard therapy the main group (n=24) received phosphocreatine (intravenous infusion dose 2 g per 100....

ea0049ep532 (1) | Diabetes complications | ECE2017

New features of pathogenetic treatment of diabetic neuropathy (DN) at on early stage

Yerdesova Kulshara , Myrzabaeva Aknur

Goal of research: To evaluate the clinical efficacy of phosphocreatine in the combined metabolic therapy of diabetic neuropathy at an early stage.Materials and methods: A pilot study was carried out with participation of 36 patients suffering from DM 2. Using the method of randomization the patients were divided into two groups. Apart from the standard therapy the main group (n=24) received phosphocreatine (intravenous infusion dose 2 g per 100....

ea0056p1077 | Thyroid (non-cancer) | ECE2018

Effective complex treatment of endocrinous ophthalmopathy (EO) with ophthalmic hyperthyroidism resistent to steroid therapy

Yerdesova Kulshara , Myrzabaeva Aknur

Methods: With the purpose of evaluation of the condition of microlymphocirculation and the efficacy of lymph-stimulating medicines patients are divided into 2 groups: the reference group (p41) - traditional treatment (Thyrozol, Anaprilin). The main group (p16) – traditional treatment + Dalargin (Tyr-D-Ala-Gly-Phe-Leu-Arg, equivalent of leu-enkephalin) 1mg (per 2.0 0.9% NaCl) SC into the lateral part of the eyes No.7. Fluorescent lymphangiography, lymphoscopy, determinatio...